Blog

Bluetail Medical Group Receives FDA IDE Approval for Pivotal Study of the Use of Cellular Therapy in the Treatment of Knee Osteoarthritis

Bluetail Medical Group Emerges as the Standard for Orthopedic Regenerative Medicine Under New FDA Regulatory Framework

In our practice at Bluetail Medical Group, we frequently have the privilege of caring for a wide array of athlete types. Their activity of choice may differ, but there are some innate truths to these types of patients.

You’ve likely seen it in many a televised marathon – a runner grimacing, hobbling and possibly collapsing as they cross the finish line of a race.

Parenting today has its own unique challenges, from keeping kids healthy in a time when “convenience food” is more readily available than ever before to keeping them safe on the Internet and active on the athletic field.

On the field, track, or in the gym, performance is everything. So, it is no surprise that virtually every athlete involved in competitive sports is looking to improve their performance in significant ways.

As the health benefits of regenerative medicine and stem cell therapy become more widely discussed in the public setting, we expert medical providers find that people talking about this burgeoning field of medicine isn’t the same as people understanding it